NASDAQ:SIEN - Sientra Stock Price, Price Target & More

Sientra trades on the NASDAQ under the ticker symbol "SIEN."

Sientra (NASDAQ:SIEN) released its quarterly earnings results on Wednesday, May, 9th. The medical instruments supplier reported ($0.99) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.84) by $0.15. The medical instruments supplier earned $14.60 million during the quarter, compared to the consensus estimate of $14.49 million. Sientra had a negative return on equity of 181.25% and a negative net margin of 164.72%. Sientra's quarterly revenue was up 95.2% on a year-over-year basis. During the same period in the previous year, the company earned $0.61 earnings per share. View Sientra's Earnings History.

7 Wall Street analysts have issued twelve-month price objectives for Sientra's stock. Their forecasts range from $12.00 to $19.00. On average, they expect Sientra's share price to reach $16.00 in the next year. View Analyst Ratings for Sientra.

Sientra saw a increase in short interest during the month of April. As of April 30th, there was short interest totalling 3,202,217 shares, an increase of 62.8% from the April 13th total of 1,966,788 shares. Based on an average daily volume of 700,192 shares, the days-to-cover ratio is presently 4.6 days. Currently, 23.0% of the company's shares are sold short.

Some companies that are related to Sientra include Consort Medical (CSRMY), Invacare (IVC), RTI Surgical (RTIX), Lakeland Industries (LAKE), ConforMIS (CFMS), Histogenics (HSGX), Rewalk Robotics (RWLK), NanoVibronix (NAOV), Helomics (AIPT), Allied Healthcare Products (AHPI), Bionik Laboratories (BNKL) and Avitar (AVTI).

Media coverage about SIEN stock has trended somewhat positive recently, according to Accern Sentiment. The research group ranks the sentiment of news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Sientra earned a news sentiment score of 0.19 on Accern's scale. They also assigned media headlines about the medical instruments supplier an impact score of 46.61 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

Sientra's stock is owned by a variety of of institutional and retail investors. Top institutional investors include ABINGWORTH LLP (8.90%), Cannell Capital LLC (5.89%), BlackRock Inc. (3.90%), Bamco Inc. NY (2.99%), Senzar Asset Management LLC (2.69%) and Millennium Management LLC (2.26%). Company insiders that own Sientra stock include Jeffrey M Nugent, Patrick F Williams, R Scott Greer and Timothy Haines. View Institutional Ownership Trends for Sientra.

SIEN stock was purchased by a variety of institutional investors in the last quarter, including Millennium Management LLC, Cannell Capital LLC, Bamco Inc. NY, X Square Capital LLC, Senzar Asset Management LLC, Monarch Partners Asset Management LLC, Blair William & Co. IL and Quantum Capital Management. Company insiders that have bought Sientra stock in the last two years include Jeffrey M Nugent, Patrick F Williams, R Scott Greer and Timothy Haines. View Insider Buying and Selling for Sientra.

Shares of SIEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of SIEN stock can currently be purchased for approximately $17.48.

Sientra has a market capitalization of $486.72 million and generates $36.54 million in revenue each year. The medical instruments supplier earns $-64,020,000.00 in net income (profit) each year or ($2.82) on an earnings per share basis. Sientra employs 200 workers across the globe.

Sientra's mailing address is 420 SOUTH FAIRVIEW AVENUE SUITE 200, SANTA BARBARA CA, 93117. The medical instruments supplier can be reached via phone at 805-562-3500 or via email at [email protected]